Modern Weight ScienceAbout

Interactive tool

GLP-1 Weight Tracker: Chart Your Progress vs the Trials

Losing weight on a GLP-1 is a slow, week-by-week process, and it is hard to know whether your own results are on track without something to compare them against. This tracker plots your weight over time and lays your body-weight-loss curve next to the published trial average for your medication, so you can see at a glance whether you are ahead of, on, or behind the study mean. It runs entirely in your browser, stores nothing on a server, and lets you export your history to CSV whenever you want.

Updated 6 min read0 peer-reviewed sources
Loading your tracker…

A GLP-1 lowers your weight gradually, and the day-to-day scale readings bounce around enough that real progress is easy to miss and easy to catastrophize. The point of tracking is to pull back from the noise of any single morning and see the trend, then to judge that trend against something meaningful. This tracker does both: it plots your weight over the weeks and draws the published trial average for your drug right beside it.

How to use the tracker

Set it up once with your starting weight, an optional goal weight, your start date, and your medication. From then on, add a weight whenever you step on the scale, ideally once a week at a consistent time. The chart updates immediately, showing the percentage of your body weight you have lost as a solid line, with the trial-average curve as a dashed line for comparison. The stat cards above the chart summarise your total loss, the percentage lost, and how far you are from your goal.

Why compare against the trial average?

Percentages travel better than pounds. Two people who each lose 15 pounds have done very different things if one started at 180 and the other at 300, so the pivotal trials report results as a percentage of starting body weight. Framing your own results the same way lets you compare fairly against the study means: about 14.9% over 68 weeks for semaglutide in STEP 1, and about 20.9% over 72 weeks for tirzepatide in SURMOUNT-1. Our guide to weight loss on semaglutide explains where these figures come from, and the GLP-1 weight-loss timeline covers what a normal month-by-month trajectory looks like.

Being behind the line is normal

The trial curves are smooth averages reached over more than a year, alongside structured diet and activity support. Real progress is lumpier. It is completely normal to sit below the dashed line for stretches, to hit a plateau, or to lose faster early and slower later. The comparison is a reference point, not a target you are failing to hit. If your loss has genuinely stalled, our article on not losing weight on Ozempic walks through the common reasons, and the fix is usually a conversation with your prescriber rather than any change you make on your own.

Your data stays yours

Everything you enter is stored only in your browser using localStorage. Nothing is uploaded, no account is needed, and no one else can see it. The trade-off is that clearing your browser data will delete your history, so the Export CSV button lets you download a copy any time to keep a backup or move it into a spreadsheet. This privacy-first design is deliberate: your weight is personal, and a tracker should not require you to hand it over to use it.

What the tracker will not do

It will not set or change your dose, diagnose a plateau, or tell you whether your rate of loss is a medical problem. It shows your trend and a study reference, and it leaves clinical judgment to your clinician. Used the way it is intended, as a clear picture of your trend against a sensible benchmark, it turns a stressful daily number into a calm weekly one. For realistic expectations before you start, see our guide to setting realistic weight-loss goals on a GLP-1.

Frequently Asked Questions

Is this GLP-1 weight tracker free and private?

Yes. It is completely free and requires no account. Every weight you log is stored only in your own browser using localStorage, and nothing is sent to any server. Because the data lives on your device, clearing your browser data will erase it, so use the Export CSV button to keep a backup.

How does it compare my progress to the clinical trials?

When you pick your medication, the tracker draws a dashed line showing the average body-weight loss from that drug's pivotal trial: about 14.9% over 68 weeks for semaglutide (STEP 1) and about 20.9% over 72 weeks for tirzepatide (SURMOUNT-1). Your own logged weights are plotted as a solid line on the same chart, so you can see whether you are tracking ahead of or behind the study average.

What should I do if I am below the trial average?

Individual results vary widely, and the trial figures are averages reached over roughly 12 to 17 months alongside diet and activity changes, so being behind the line at any given week is common and not a failure. Weight loss is rarely linear and often includes plateaus. If your loss has stalled or you are concerned, the best step is a conversation with your prescriber about dose, adherence, and nutrition rather than any change on your own.

Does the tracker work for Ozempic, Mounjaro, and Zepbound?

Yes. Ozempic and Wegovy are both semaglutide, and Mounjaro and Zepbound are both tirzepatide, so choose semaglutide or tirzepatide to match your medication. Saxenda (liraglutide) is also included. If you are unsure or using something else, choose 'Other' and the tracker will still plot your own curve without a trial comparison line.

Not medical advice. This resource is for general education only. Medications, dosing, and treatment suitability are decisions for you and a licensed clinician who knows your full medical history.

Last updated · 6 min read

Weekly Digest

Get Evidence-Based Metabolic Health Insights Weekly

Research-backed insights on metabolism, GLP-1 science, and sustainable weight management — once a week.

No spam. Unsubscribe any time.